Clasado Biosciences, a global leader in the innovative development of clinically proven prebiotic ingredient and product solutions for the human gut microbiome, has appointed a new member to the board of Clasado Inc.
Clasado Inc is the company’s commercial organisation for North America. Niklas Bjärum joins to focus on the strategic commercial development of the business in North America..
Per Rehné, Clasado Chief Executive Officer, said: “We are delighted to welcome Niklas to Clasado. His industry experience will be instrumental to the development of the business and his appointment will be a crucial element of our drive to boost the presence of Clasado in the North American region.”
Niklas’s appointment adds a valuable breadth of industry experience to the board as the business continues to develop into an innovation led commercially-driven company. He has over 15 years’ experience as Vice President – Marketing & Sales at Probi AB, a bioengineering company which researches, develops, manufactures, markets and sells probiotics for food, health and pharmaceutical companies. More recently, he held the role of President at Probi USA Inc, responsible for the new organisation’s implementation and integration into the Probi group. Accomplishing this, Niklas has established an international consulting business (www.cbcab.se) with a focus on Business Development and Commercial Strategy in the global Nutraceutical industry.
Clasado is a leading biotechnology pioneer in the development of microbiome science producing prebiotic ingredients and consumer products aimed at gastrointestinal wellness destined for the food and healthcare sectors.
To find out more about Clasado Biosciences, please visit www.clasado.com
